Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancer
S Ahmadi-Balootaki, A Doosti, M Jafarinia… - Genes and …, 2022 - Springer
Abstract Background The MALAT1 lncRNA acts as an oncogene in Prostate cancer (PC);
thus, it can be severe as a cancer biomarker. Methods Using bioinformatics datasets …
thus, it can be severe as a cancer biomarker. Methods Using bioinformatics datasets …
[PDF][PDF] Personalized Medicine for HIV Control: A Systematic Review Study
S Farahmandpour, N Dehghani… - Personalized Medicine …, 2023 - pmjournal.ir
AIDS is an illness that presents its victims with various issues (1). Human Immunodeficiency
Virus (HIV) is the disease's primary causal agent (2). HIV severely harms the immune …
Virus (HIV) is the disease's primary causal agent (2). HIV severely harms the immune …
Treatment Insights from Long COVID Syndrome Emerging as Neuropsychiatric Exacerbations in Autism Spectrum Disorder
N Banaei, M Saremi… - Personalized Medicine …, 2022 - pmjournal.ir
Even if the symptoms during the acute phase are minimal, COVID-19 not only results in
severe respiratory problems but also long-term consequences. Significant long-term …
severe respiratory problems but also long-term consequences. Significant long-term …
Personalized Medicine-based Microbiology Management of Infectious Diseases
N Fattahi, N Banaei, N Tavakoli Lahijani… - Personalized Medicine …, 2022 - pmjournal.ir
The current study identified pathogenic variables associated with increased mortality risk in
infectious diseases using predictive analysis and a combination of genotypic, phenotypic …
infectious diseases using predictive analysis and a combination of genotypic, phenotypic …